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E-mail address: ncella@usp.br (N. Cella).Maspin is a tumor suppressor with many biological activities, multiple ligands and different subcel-
lular localizations. Its underlying molecular mechanism remains elusive. We hypothesized that
phosphorylation might regulate maspin localization and function. Using two-dimensional gel elec-
trophoresis with different focusing power followed by Western blot we identiﬁed four different
maspin forms with the same molecular weight (42 kDa), but different isoelectric points. Three of
these forms were sensitive to acidic phosphatase treatment, suggesting that they are phosphory-
lated. Sodium peroxidovanadate treatment, a protein-tyrosine phosphatase inhibitor, resulted in
a rapid increase in maspin protein levels and cytoplasmic accumulation. These data show that there
are three different maspin tyrosine phosphoforms. Inhibition of tyrosine phosphatases increased
maspin protein levels and leads to its cytoplasmic accumulation.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Maspin (SERPINB5) is a 42 kDa non-inhibitory serpin with
tumor suppressor activity. Maspin is expressed in most epithelial
tissues and presents multiple biological activities including inhibi-
tion of tumor growth and metastasis in vivo, modulation of cell
adhesion in vitro, inhibition of cell migration and angiogenesis,
regulation of apoptosis and oxidative stress response [1]. Maspin
pleiotropic activities reﬂect its diversity of ligands and subcellular
localization [1–7]. Different maspin PTMs have been reported,
including phosphorylation [8,9], nitrosylation and intramolecular
disulﬁte bonds [10], suggesting that PTMs regulate maspin func-
tion. Initial studies reported a strong maspin tumor suppressor
activity [11], in agreement with decreased maspin expression in
tumor progression of different tumor types [11,12]. Conversely,
others have shown a poor prognosis in maspin-expressing tumors
[13–15]. Recent reports found that cytoplasmic maspin was associ-
ated with poor prognosis, whereas nuclear maspin localization was
indicative of a less aggressive lesion [16], indicating that maspinal Societies. Published by Elsevier
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5 11 3091 7402.subcellular localization, rather than expression levels, correlates
with tumor progression. Using the MFC-10A model, a non-
transformed human mammary epithelial cell line which endoge-
nously expresses maspin, we identiﬁed four maspin forms, three
of them were found phosphorylated. Cell treatment with sodium
peroxidovanadate, a tyrosine phosphatase inhibitor, increased
maspin protein levels, which accumulated predominantly in the
cytoplasm. Interestingly, high levels of acidic maspin were de-
tected in the AsPC-1 pancreatic tumor cell line, which expresses
maspin predominantly in the cytoplasm [15]. These results suggest
that tyrosine phosphorylation may play a role in maspin protein
levels and correlates with cytoplasmic accumulation.
2. Materials and methods
2.1. Cell culture
AsPC-1 and MCF-10A cells were cultivated as described [6,15].
For sodium peroxidovanadate treatment, equal volumes of
20 mM sodium orthovanadate and 20 mM hydrogen peroxide were
freshly mixed and incubated for 30 min at room temperature. Two
hundred micrograms per milliliter of catalase was added to decom-
pose unreacted hydrogen peroxide. Cell medium was changed 2 h
before peroxidovanadate treatment (25 lM) for indicated periods
of time. Control cells were incubated with the same solution with-
out peroxidovanadate [17].B.V. Open access under CC BY-NC-ND license.
Fig. 1. Maspin is phosphorylated on tyrosine residues in MCF-10A cells. Five
hundred micrograms of whole cell extract was analyzed by immunoprecipitation
followed by Western blot with the indicated antibodies. Fifty micrograms of whole
cell extract was loaded in the ﬁrst lane of the gel. Arrow and arrowhead indicate
maspin band and an unidentiﬁed molecule, respectively.
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For IEF, 90–100% conﬂuent MCF-10A or AsPC-1 cultures were
extracted in 8 M urea, 4% CHAPS, 40 mM DTT, 1X protease inhibitor
cocktail (Sigma # P2850), 1X phosphatase inhibitor cocktail (Sigma
# P2714) and cleared by centrifugation (whole cell extract). In
order to prepare an extract which is compatible with acidic phos-
phatase treatment and IEF, we used the 2D Sample Prep Kit for Nu-
clear Proteins (Pierce # 89863) according to manufacturer’s
instructions. Acidic phosphatase solution (Sigma) was freshly pre-
pared in 40 mM PIPES pH 6.0, 1 mM DTT, 20 lg/ml aprotinin and
10 mM PMSF. Protein extracts were incubated with 100 lg/ml of
acidic phosphatase (Sigma) for 30 min at 37 C. For immunoprecip-
itation, whole cell extract were prepared in modiﬁed RIPA buffer
[6] and cleared by centrifugation. Protein concentration was deter-
mined by the Bradford assay (Bio-Rad).
2.3. 2D-SDS-PAGE
90–100% conﬂuent MCF-10A cultures grown in complete
medium were used in all the experiments. Protein samples
(100–2000 lg) were applied onto 3–10 (11 cm), 4–7 (13 cm) (GE
Healthcare) or 4.7–5.9 (17 cm) (Bio-Rad) linear immobilized pH
gradient strips. Strips were rehydrated for 16 h at room tempera-
ture. IEF was performed on an IPGphor III apparatus (GE Health-
care) at 17 kV h. For the second dimension, strips were incubated
at room temperature for 20 min in equilibration buffer (6 M urea,
2% SDS, 50 mM Tris–HCl, pH 6.8, 30% glycerol and 0.001% bromo-
phenol blue with 2% DTT), followed by incubation with 4% iodoa-
cetamide in equilibrium buffer for 20 min. The second dimension
was performed in vertical 12% SDS-PAGE (Ettan DALT large vertical
electrophoresis, GE Healthcare). Proteins were transferred to PVDF
membrane and analyzed by Western blot with monoclonal anti-
maspin (Millipore MAB 4035).
2.4. Immunoprecipitation and Western blot
Two milligrams of MCF-10A RIPA buffer lysates were incubated
with rabbit anti-maspin (BD Pharmingen) or anti-phosphotyrosine
(Millipore, clone PY20) overnight at 4 C. Protein G-coupled beads
were added for 1 h at 4 C under agitation; beads were washed
with ice-cold RIPA buffer and boiled for 5 min in Laemmli buffer
under reducing conditions. Immunoprecipitated material was sep-
arated in 12% SDS-PAGE gels, transferred to PVDF membrane and
probed with monoclonal anti-maspin and anti-phosphotyrosine.
Other antibodies used in this study were anti-GAPDH (Advanced
Immuno Chemical, Inc.) and anti-a-tubulin (Sigma). Appropriate
secondary antibodies were added and immunodetection was
performed by chemiluminescence and exposure of membranes to
X-ray ﬁlms.
2.5. Immunoﬂuorescence
Sodium peroxidovanadate treatment was performed as de-
scribed in the previous section. After treatment cells were ﬁxed
with 2% paraformaldehyde in PBS for 20 min at room temperature.
The ﬁxed cells were permeabilized with 0.05% Triton X-100 in
blocking buffer (5% goat serum in PBS) for 1 h at room tempera-
ture. Cells were then incubated in 1:100 diluted monoclonal anti-
maspin (BD Pharmingen) in blocking buffer and Alexa-Fluor 568
anti-mouse secondary antibody. Cells were counterstained with
0.1 mg/ml Hoechst dye to visualize the nuclei. Images were
obtained with an Axiophot wideﬁeld ﬂuorescence microscope
using a 63 PlanApo 1.4 NA objective (Carl Zeiss). Images were ac-
quired using a digital CCD monochromatic camera (CoolSnap HQ2,
Photometrics Inc., Tucson, AZ, USA). The microscope and all deviceswere controlled by Metamorph Premier 7.6 software (Molecular
Devices, Sunnyvale, CA, USA). Fluorescence intensity and localiza-
tion were measured using ImageJ public domain software.
3. Results and discussion
Maspin phosphorylation has been previously described in
mammary and corneal epithelial cells [8,9]. Whereas multiple ser-
ine sites have been identiﬁed, maspin tyrosine phosphorylation
and function has not been explored yet. To initially verify if maspin
is phosphorylated on tyrosine residues in MCF-10A cells, whole cell
lysates were immunoprecipitated with anti-maspin and anti-phos-
photyrosine and analyzed by immunoblot with anti-maspin and
anti-phosphotyrosine (Fig. 1). A strong maspin band was detected
in the material immunoprecipitated by anti-phosphotyrosine, as
well as a weaker band (Fig. 1, lane 3, arrow and arrowhead, respec-
tively). The high molecular weight form was not pursued in this
study. We were unable to detect phosphotyrosines in the material
immunoprecipitated by different monoclonal and polyclonal mas-
pin antibodies (data not shown), even though maspin could be efﬁ-
ciently immunoprecipitated (Fig. 1, lane 2). This result suggests
that a small fraction of the maspin intracellular pool is phosphor-
ylated on tyrosine residues under our experimental condition.
Since addition of a phosphate group adds a negative charge to
the protein, we reasoned we would be able to detect different mas-
pin forms by IEF followed by Western blot. For this purpose 100 lg
of whole cell extract were analyzed on an 11 cm pH 3–10 linear
gradient IPG strip. A predominant spot (Fig. 2A, arrow) next to a
possible precursor of an independent spot (Fig. 2A, arrowhead)
was detected with anti-maspin. By this ﬁrst analysis maspin pI
was estimated to be around 5.65, which approaches a previous
prediction [8]. In a second analysis 700 lg was applied on a
13 cm IPG strip with a narrower pH gradient (pH 4–7). Two distinct
spots could be detected, a strong one and a more acidic less abun-
dant spot (Fig. 2B, arrow and arrowhead, respectively). In order to
increase the relative focusing power and reach the ﬁnest possible
resolution, 2 mg of whole cell extract were applied to a 17 cm strip
with a micro-range gradient (pH 4.7–5.9). Four different spots
were detected (Fig. 2C, arrows). In order to conﬁrm these spots
were due to phosphorylation, maspin was immunoprecipitated
fromwhole cell extract and immunoprecipitated material was ana-
lyzed by 2D-SDS-PAGE followed by Western blot with anti-phos-
photyrosine. In at least four different attempts using different
Fig. 2. Identiﬁcation of different maspin forms in MCF-10A cells. Whole cell extracts were analyzed by 2D-SDS-PAGE followed by Western blot with anti-maspin. Isolectric
focalizations were carried out in three different IPG strips: (A) 100 lg protein/11 cm pH 3–10; (B) 700 lg/13 cm pH 4–7 and (C) 2000 lg/17 cm pH 4.7–5.9. Arrows and
arrowhead indicate different maspin forms.
Fig. 3. Maspin phosphorylated forms. Two milligrams of protein extracts were
analyzed by 2D-SDS-PAGE using 17 cm pH 4.7–5.9 IPG strips followed by Western
blot with anti-maspin. (A) MCF-10A nuclear extracts; (B) MCF-10A nuclear extracts
treated for 30 min with acidic phosphatase; (C) MCF-10A cells were treated with
25 lM sodium peroxidovanadate for 90 min before whole cell extraction. Arrow
indicates maspin phosphoforms not observed in previous analyses; (D) AsPC-1 total
cell extracts. Arrows indicate maspin spots which resemble spots detected in 3C.
Arrowhead indicates a strong acidic maspin form.
Fig. 4. Peroxidovanadate leads to rapid increase in maspin levels in MCF-10A cells.
(A) Cells were treated with 25 lM sodium peroxidovanadate for 15, 45 and
90 minutes and 50 lg of whole cell extract was analyzed by Western blot (upper
panel). The membrane was reprobed with anti-a-tubulin for a loading control
(lower panel). (B) Maspin signal was quantiﬁed and normalized to the level of a-
tubulin.
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phosphotyrosine (data not shown), in accordance with what we
observed in experiment shown in Fig. 1. A previous study could
not detect phosphotyrosine in corneal epithelial cell lysates immu-
noprecipitated with anti-maspin either [8]. Therefore, we suspect
maspin tyrosine phosphoforms are not efﬁciently immunoprecipi-
tated by the commercially available maspin antibodies. Since mas-
pin is present in multiple cellular compartments and it is also
detected in the Triton X-100 insoluble cytoskeleton fraction [6],
cells lysates were prepared in a strongly denaturing and chaotropic
solution containing 8 M urea (see Section 2), to reassure that mas-
pin associated with the different cellular components would be ex-
tracted. However, this extraction solution precludes the
phosphatase treatment of the extract. To circumvent this experi-
mental limitation, we acquired a kit for nuclear extraction which
is compatible with both IEF and acidic phosphatase treatment (de-
scribed in Section 2). Two milligrams of nuclear extract was ana-
lyzed by 2D-SDS-PAGE followed by Western blot with anti-
maspin. Four maspin spots were detected in this fraction
(Fig. 3A), which present a similar distribution pattern observed in
whole cell extract (Fig. 2C). Acidic phosphatase treatment of the
extract followed by similar analysis completely abolished three
of the four spots initially detected (Fig. 3B), indicating that these
three spots are phosphorylated maspin. To further support the
phosphorylation of maspin forms and conﬁrm that it occurs on
tyrosine residues, MCF-10A cells were treated with sodium perox-
idovanadate for 90 min. Whole cell extracts were prepared and
analyzed by 2D-SDS-PAGE followed by Western blot withanti-maspin. We observed a strong increase in maspin spots
(Fig. 3C), indicating that maspin is phosphorylated on tyrosine,
and an increase on overall maspin levels as well. Interestingly,
we observed a smeared spot which was not apparent in the un-
treated extracts (Fig. 3C, arrow), indicating that there might be
more maspin tyrosine phosphoforms which are present in very
low levels in the cells. In addition, this result suggests that maspin
tyrosine phosphorylation might be hold in check by tyrosine
phosphatases.
To gain some insight into the biological role of maspin tyrosine
phosphorylation, maspin protein levels and subcellular localiza-
tion were investigated. MCF-10A cells were treated with peroxido-
vanadate for 15, 45 and 90 min and whole cell extract was
analyzed by Western blot. A 35% increase in maspin protein levels
was detected after 15 min of peroxidovanadate treatment
(Fig. 4A). This level did not change after 45 min and further in-
creased 77.7% in 90 min (Fig. 4B). The rapid increase in maspin
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increase in maspin spots (Fig. 3C). In order to visualize maspin
increment, MCF-10A cells were treated with peroxidovanadate
for 90 min, ﬁxed and processed for immunoﬂuorescence with
anti-maspin monoclonal antibody. Maspin total levels signiﬁcantly
increased upon peroxidovanadate treatment (Fig. 5A and B), in
good agreement with the Western blot and the IEF (Figs. 4A and
3C, respectively). Interestingly, quantiﬁcation of the cytoplasmic
and nuclear maspin revealed that there is 1.8 times more maspin
in the cytoplasm than in the nucleus of peroxidovanadate-treated
cells, whereas maspin appears equally distributed between these
two compartments in control cells (Fig. 5B). These results suggest
that tyrosine phosphorylation plays a role in maspin protein levels
and leads to cytoplasmic accumulation.
Because growing evidence indicates that in tumor cells, greater
cytoplasmic than nuclear maspin correlates with tumor progres-
sion, we looked at maspin spots in the AsPC-1 pancreatic tumor
cell line, which expresses maspin mostly in the cytoplasm [15].
AsPC-1 whole cell extracts were prepared and analyzed by 2D-
SDS-PAGE followed by Western blot with anti-maspin. Three
maspin spots were detected (Fig. 3D, arrows), which resembles
those found in peroxidovanadate-treated MCF-10A cells (compare
spots in 3C and 3D). Interestingly, a more acidic maspin form
(estimated pI  5.2) was strongly expressed in AsPC-1 cells
(Fig. 3D, arrowhead). The similarity between the spot pattern
found in AsPC-1 and in peroxidovanadate-treated MCF-10A cellsFig. 5. Maspin cytoplasmic accumulation in peroxidovanadate-treated MCF-10A cells. (
processed for immunoﬂuorescence with anti-maspin monoclonal antibody. Nuclei were c
maspin were quantiﬁed and expressed in arbitrary units. Scale bars – 10 lm.suggests that maspin is phosphorylated on tyrosine in AsPC-1
cells as well. This observation further supports the correlation be-
tween maspin phosphorylation and cytoplasmic accumulation
and indicates a possible link between maspin tyrosine phosphor-
ylation and tumor progression. Phosphorylation of nuclear locali-
zation and nuclear export signals regulates nucleocytoplasmic
trafﬁcking, affecting gene transcription, cell cycle and prolifera-
tion [18]. Identiﬁcation of the phosphorylated residues and site-
directed mutagenesis will help to elucidate if maspin phosphory-
lation plays a causative role in maspin nuclear localization. The
strong increase in maspin phosphoforms upon peroxidovanadate
treatment suggests that intracellular maspin is predominantly
phosphorylated on tyrosine residues (Fig. 3B). In agreement with
our result, a recent study reported that maspin tyrosine phos-
phorylation was found in the intracellular compartment of cor-
neal epithelial cells, but not in the secreted form [8]. These
results may indicate that maspin phosphorylation on serine/thre-
onine versus tyrosine could play a role in maspin secretion, as
well as subcellular localization. Clinical studies suggest that mas-
pin nuclear localization is indicative of better prognosis [19,20].
In agreement with these observations, exclusion of maspin from
the nucleus abrogates its tumor suppressor activity [21]. This
study is the ﬁrst to address the biological role of maspin tyrosine
phosphorylation. In addition, it indicates a possible mechanism
for maspin subcellular localization, which can be a promising
therapeutic target.A) Cells were treated with 25 lM sodium peroxidovanadate for 90 min, ﬁxed and
ounterstained with Hoechst dye. (B) Total maspin as well as cytoplasmic and nuclear
M. Tamazato Longhi, N. Cella / FEBS Open Bio 2 (2012) 93–97 97Acknowledgements
We are grateful to Dr. Roger Chammas for critically reviewing
this manuscript, to Dr. Vanessa Morais Freitas for assistance with
ﬂuorescence images and to Dr. Walter Colli and Dr. Maria Julia
M. Alves for their generous support. This research was supported
by FAPESP (05/60353-8 and 06/53590-6) to N. Cella and FAPESP
2009/12597-6 to M.T. Longhi.
References
[1] Bailey, C.M., Khalkhali-Ellis, Z., Seftor, E.A. and Hendrix, M.J. (2006) Biological
functions of maspin. J. Cell. Physiol. 209, 617–624.
[2] Endsley, M.P., Hu, Y., Deng, Y., He, X., Warejcka, D.J., Twining, S.S., Gonias, S.L.
and Zhang, M. (2011) Maspin, the molecular bridge between the plasminogen
activator system and beta1 integrin that facilitates cell adhesion. J. Biol. Chem.
286, 24599–24607.
[3] Li, X., Yin, S., Meng, Y., Sakr, W. and Sheng, S. (2006) Endogenous inhibition of
histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 66, 9323–
9329.
[4] Blacque, O.E. and Worrall, D.M. (2002) Evidence for a direct interaction
between the tumor suppressor serpin, maspin, and types I and III collagen. J.
Biol. Chem. 277, 10783–10788.
[5] Bailey, C.M. et al. (2005) Mammary serine protease inhibitor (maspin) binds
directly to interferon regulatory factor 6: identiﬁcation of a novel serpin
partnership. J. Biol. Chem. 280, 34210–34217.
[6] Cella, N., Contreras, A., Latha, K., Rosen, J.M. and Zhang, M. (2006) Maspin is
physically associated with [beta]1 integrin regulating cell adhesion in
mammary epithelial cells. FASEB J. 20, 1510–1512.
[7] Yin, S., Li, X., Meng, Y., Finley Jr., R.L., Sakr, W., Yang, H., Reddy, N. and Sheng, S.
(2005) Tumor-suppressive maspin regulates cell response to oxidative stress
by direct interaction with glutathione S-transferase. J. Biol. Chem. 280, 34985–
34996.
[8] Narayan, M., Mirza, S.P. and Twining, S.S. (2011) Identiﬁcation of
phosphorylation sites on extracellular corneal epithelial cell maspin.
Proteomics 11, 1382–1390.[9] Odero-Marah, V.A., Khalkhali-Ellis, Z., Schneider, G.B., Seftor, E.A., Seftor, R.E.,
Koland, J.G. and Hendrix, M.J. (2002) Tyrosine phosphorylation of maspin in
normal mammary epithelia and breast cancer cells. Biochem. Biophys. Res.
Commun. 295, 800–805.
[10] Nawata, S., Shi, H.Y., Sugino, N. and Zhang, M. (2010) Evidence of post-
translational modiﬁcation of the tumor suppressor maspin under oxidative
stress. Int. J. Mol. Med. 27, 249–254.
[11] Zou, Z. et al. (1994) Maspin, a serpin with tumor-suppressing activity in
human mammary epithelial cells. Science 263, 526–529.
[12] Heighway, J. et al. (2002) Expression proﬁling of primary non-small cell lung
cancer for target identiﬁcation. Oncogene 21, 7749–7763.
[13] Smith, S.L., Watson, S.G., Ratschiller, D., Gugger, M., Betticher, D.C. and
Heighway, J. (2003) Maspin – the most commonly-expressed gene of the
18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic
bronchial lesions. Oncogene 22, 8677–8687.
[14] Umekita, Y. and Yoshida, H. (2003) Expression of maspin is up-regulated
during the progression of mammary ductal carcinoma. Histopathology 42,
541–545.
[15] Maass, N., Hojo, T., Ueding, M., Luttges, J., Kloppel, G., Jonat, W. and Nagasaki,
K. (2001) Expression of the tumor suppressor gene maspin in human
pancreatic cancers. Clin. Cancer Res. 7, 812–817.
[16] Goulet, B., Chan, G., Chambers, A.F. and Lewis, J.D. (2012) An emerging role for
the nuclear localization of maspin in the suppression of tumor progression
and metastasis. Biochem. Cell Biol. 90, 22–38.
[17] Posner, B.I. et al. (1994) Peroxovanadium compounds. A new class of potent
phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol.
Chem. 269, 4596–4604.
[18] Nardozzi, J.D., Lott, K. and Cingolani, G. (2010) Phosphorylation meets nuclear
import: a review. Cell Commun. Signal 8, 32.
[19] Mohsin, S.K., Zhang, M., Clark, G.M. and Craig Allred, D. (2003) Maspin
expression in invasive breast cancer: association with other prognostic
factors. J. Pathol. 199, 432–435.
[20] Sood, A.K. et al. (2002) The paradoxical expression of maspin in ovarian
carcinoma. Clin. Cancer Res. 8, 2924–2932.
[21] Goulet, B. et al. (2011) Nuclear localization of maspin is essential for its
inhibition of tumor growth and metastasis. Lab. Invest. 91, 1181–1187.
